Investors Heavily Search KB Home (KBH): Here is What You Need to Know

28.03.25 14:00 Uhr

Werte in diesem Artikel
Aktien

52,50 EUR -2,00 EUR -3,67%

Indizes

1.854,4 PKT -8,4 PKT -0,45%

KB Home (KBH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this homebuilder have returned -3% over the past month versus the Zacks S&P 500 composite's -2.8% change. The Zacks Building Products - Home Builders industry, to which KB Home belongs, has gained 0.2% over this period. Now the key question is: Where could the stock be headed in the near term?While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.For the current quarter, KB Home is expected to post earnings of $1.78 per share, indicating a change of -17.2% from the year-ago quarter. The Zacks Consensus Estimate has changed -15.4% over the last 30 days.For the current fiscal year, the consensus earnings estimate of $7.77 points to a change of -8.1% from the prior year. Over the last 30 days, this estimate has changed -7.6%.For the next fiscal year, the consensus earnings estimate of $8.29 indicates a change of +6.7% from what KB Home is expected to report a year ago. Over the past month, the estimate has changed -9.3%.With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for KB Home.The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSRevenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.For KB Home, the consensus sales estimate for the current quarter of $1.67 billion indicates a year-over-year change of -2.3%. For the current and next fiscal years, $7.02 billion and $7.15 billion estimates indicate +1.3% and +1.9% changes, respectively.Last Reported Results and Surprise HistoryKB Home reported revenues of $1.39 billion in the last reported quarter, representing a year-over-year change of -5.2%. EPS of $1.49 for the same period compares with $1.76 a year ago.Compared to the Zacks Consensus Estimate of $1.5 billion, the reported revenues represent a surprise of -7.37%. The EPS surprise was -4.49%.Over the last four quarters, KB Home surpassed consensus EPS estimates two times. The company topped consensus revenue estimates three times over this period.ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.KB Home is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about KB Home. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report KB Home (KBH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: KB Home und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Here

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Here

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu KB Home

Wer­bung

Analysen zu KB Home

DatumRatingAnalyst
23.08.2019KB Home BuySeaport Global Securities
01.07.2019KB Home NeutralBTIG Research
13.05.2019KB Home OverweightBarclays Capital
23.03.2018KB Home UnderweightBarclays Capital
17.01.2018KB Home SellUBS AG
DatumRatingAnalyst
23.08.2019KB Home BuySeaport Global Securities
13.05.2019KB Home OverweightBarclays Capital
20.09.2016KB Home OutperformWedbush Morgan Securities Inc.
14.01.2015KB Home BuyMKM Partners
28.03.2012KB Home outperformRBC Capital Markets
DatumRatingAnalyst
01.07.2019KB Home NeutralBTIG Research
29.12.2017KB Home NeutralWedbush Morgan Securities Inc.
28.06.2017KB Home Sector PerformRBC Capital Markets
24.03.2017KB Home Sector PerformRBC Capital Markets
21.09.2016KB Home Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.03.2018KB Home UnderweightBarclays Capital
17.01.2018KB Home SellUBS AG
25.10.2017KB Home SellUBS AG
06.01.2017KB Home UnderweightBarclays Capital
22.06.2016KB Home SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für KB Home nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen